See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2015_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 203,478,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 43,905,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,223,000 |
| 3 | remainder_Assets | 11,103,000 |
| 4 | LiabilitiesCurrent | 13,233,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 110,691,000 |
| 7 | CostOfGoodsAndServicesSold | 11,738,112 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,505,489 |
| 9 | ResearchAndDevelopmentExpense | 2,469,055 |
| 10 | remainder_Expenses | 1,398,628 |
| 11 | remainder_Revenues | 183,118,740 |
| 12 | remainder_NetIncome | -510,001 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 263,709,000 |
| 1 | Liabilities | 123,924,000 |
| 2 | Expenses | 34,111,284 |
| 3 | Revenues | 183,118,740 |
| 4 | StockholdersEquity | 139,785,000 |
| 5 | NetIncome | 148,497,455 |
| 6 | ComprehensiveNetIncome | 148,497,455 |
| 7 | BaseVar | 302,686,512 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.34 |
| 9 | EconomicCapitalRatio | 3.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
